| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Spiros Miyakis | |
| Athanassios Tsakris | |||
| Angelos Pefanis | |||
| P2860 | cites work | Carbapenemases: the versatile beta-lactamases | Q24685034 |
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case-control study | Q33909443 | ||
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. | Q34096605 | ||
| Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. | Q34116236 | ||
| The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa | Q34581987 | ||
| Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies | Q34803735 | ||
| Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing | Q35793289 | ||
| Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections | Q36095874 | ||
| CTX-M: changing the face of ESBLs in Europe | Q36678524 | ||
| Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis | Q36937529 | ||
| Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections | Q37190732 | ||
| Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. | Q37274659 | ||
| Clinical and economic burden of antimicrobial resistance. | Q37291374 | ||
| Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. | Q37677832 | ||
| Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe | Q37718313 | ||
| Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of enterobacteriaceae by incorporating boronic Acid | Q39901425 | ||
| In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus | Q41931817 | ||
| Emerging Klebsiella pneumoniae isolates coproducing KPC-2 and VIM-1 carbapenemases. | Q42545854 | ||
| Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory | Q42555263 | ||
| Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae | Q42613465 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009) | Q42855427 | ||
| Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo- -lactamase | Q42874712 | ||
| Serotypes and susceptibilities of paediatric clinical isolates of Streptococcus pneumoniae in Crete, Greece, before and after the heptavalent pneumococcal conjugate vaccine | Q42975273 | ||
| A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates | Q43027582 | ||
| Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007. | Q43104424 | ||
| An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes | Q43204996 | ||
| Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa | Q44251526 | ||
| Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece | Q44740511 | ||
| Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients | Q44850427 | ||
| Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. | Q45236129 | ||
| Risk factors for coexistence of fluoroquinolone resistance and ESBL production among Enterobacteriaceae in a Greek university hospital. | Q46448501 | ||
| Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit | Q46657422 | ||
| Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital | Q46758181 | ||
| Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci | Q46898757 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus infections | Q46901638 | ||
| Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase | Q48007849 | ||
| Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. | Q54372089 | ||
| First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. | Q54438035 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Greece | Q41 |
| antimicrobial resistance | Q63391344 | ||
| P304 | page(s) | 177-184 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The challenges of antimicrobial drug resistance in Greece | |
| P478 | volume | 53 |
| Q64260333 | A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015-2016 |
| Q86026305 | Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure |
| Q42160577 | Acinetobacter baumannii infection in prior ICU bed occupants is an independent risk factor for subsequent cases of ventilator-associated pneumonia |
| Q34194422 | An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis |
| Q34726077 | Antibacterial Treatment of Meticillin-Resistant Staphylococcus Aureus Complicated Skin and Soft Tissue Infections: a Cost and Budget Impact Analysis in Greek Hospitals. |
| Q26767081 | Carbapenem resistance: overview of the problem and future perspectives |
| Q36180580 | Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland |
| Q36806881 | Clinical treatment of pandrug-resistant bacterial infection consulted by clinical pharmacist |
| Q50934594 | Colonization of high-risk children with carbapenemase-producing Enterobacteriaceae in Greece. |
| Q38199180 | Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria |
| Q41581468 | Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens |
| Q37268642 | Control of a Multi-Drug-Resistant Acinetobacter baumannii Outbreak after Orthopedics Department Relocation |
| Q28485168 | Could public restrooms be an environment for bacterial resistomes? |
| Q38430967 | Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade |
| Q64078801 | Evaluating the Efficacies of Carbapenem/β-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria and |
| Q37643655 | Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments. |
| Q92861076 | Gram-negative bacteria as emerging pathogens affecting mortality in skin and soft tissue infections |
| Q38672110 | Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015). |
| Q52592585 | Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data. |
| Q40045601 | On the ferries: the unmet health care needs of transiting refugees in Greece |
| Q55379739 | Prescription audit in a paediatric sickle cell clinic in South-West Nigeria: A cross-sectional retrospective study. |
| Q60045376 | Resistance profile of clinically relevant bacterial isolates against fluoroquinolone in Ethiopia: a systematic review and meta-analysis |
| Q47168090 | Six-Year Retrospective Review of Hospital Data on Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from Skin Infections from a Single Institution in Greece. |
| Q35107094 | The Japanese guidelines for the management of sepsis |
| Q27005826 | There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy |
| Q50689978 | Trends of isolation of intrinsically resistant to colistin Enterobacteriaceae and association with colistin use in a tertiary hospital. |
| Q36976799 | Trends of mortality due to septicemia in Greece: an 8-year analysis |
| Q40758595 | Whole-genome typing and characterization of blaVIM19-harbouring ST383 Klebsiella pneumoniae by PFGE, whole-genome mapping and WGS. |
Search more.